{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:30:59Z","timestamp":1777372259035,"version":"3.51.4"},"reference-count":42,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Data"],"abstract":"<jats:p>Our goal was to find new diagnostic and prognostic biomarkers in bladder cancer (BCa), and to predict molecular mechanisms and processes involved in BCa development and progression. Notably, the data collection is an inevitable step and time-consuming work. Furthermore, identification of the complementary results and considerable literature retrieval were requested. Here, we provide detailed information of the used datasets, the study design, and on data mining. We analyzed differentially expressed genes (DEGs) in the different datasets and the most important hub genes were retrieved. We report on the meta-data information of the population, such as gender, race, tumor stage, and the expression levels of the hub genes. We include comprehensive information about the gene ontology (GO) enrichment analyses and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses. We also retrieved information about the up- and down-regulation of genes. All in all, the presented datasets can be used to evaluate potential biomarkers and to predict the performance of different preclinical biomarkers in BCa.<\/jats:p>","DOI":"10.3390\/data5020038","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T05:15:41Z","timestamp":1587014141000},"page":"38","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Bioinformatics Analysis Identifying Key Biomarkers in Bladder Cancer"],"prefix":"10.3390","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1980-8387","authenticated-orcid":false,"given":"Chuan","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Urology, University of Leipzig, 04103 Leipzig, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandy","family":"Berndt-Paetz","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Leipzig, 04103 Leipzig, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2484-6994","authenticated-orcid":false,"given":"Jochen","family":"Neuhaus","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Leipzig, 04103 Leipzig, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,4,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Kulkarni, G.S., Black, P.C., Sridhar, S.S., Kapoor, A., Zlotta, A.R., Shayegan, B., Rendon, R.A., Chung, P., van der Kwast, T., and Alimohamed, N. (2019). Canadian Urological Association guideline: Muscle-invasive bladder cancer. Can. Urol. Assoc. J., 230\u2013238.","DOI":"10.5489\/cuaj.5902"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.6004\/jnccn.2018.0072","article-title":"NCCN Guidelines Insights: Bladder Cancer, Version 5.2018","volume":"16","author":"Flaig","year":"2018","journal-title":"J. Natl. Compr. Cancer Netw. JNCCN"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) 2019 Update","volume":"76","author":"Babjuk","year":"2019","journal-title":"Eur. Urol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e174591","DOI":"10.1001\/jamasurg.2017.4591","article-title":"Adjuvant Sandwich Chemotherapy Plus Radiotherapy vs. Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy: A Randomized Phase 2 Trial","volume":"153","author":"Zaghloul","year":"2018","journal-title":"JAMA Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pdpdt.2017.02.017","article-title":"Tetrahydroporphyrin-tetratosylat (THPTS): A near-infrared photosensitizer for targeted and efficient photodynamic therapy (PDT) of human bladder carcinoma. An in vitro study","volume":"18","author":"Weimann","year":"2017","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/pho.2016.4217","article-title":"Photodynamic Diagnosis and Narrow-Band Imaging in the Management of Bladder Cancer: A Review","volume":"35","author":"Kutwin","year":"2017","journal-title":"Photomed. Laser Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3233\/BLC-150034","article-title":"Comparison of Guidelines on Non-Muscle Invasive Bladder Cancer (EAU, CUA, AUA, NCCN, NICE)","volume":"2","author":"Power","year":"2016","journal-title":"Bladder Cancer (Amst. Neth.)"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.7150\/ijbs.32718","article-title":"Increased expression of TRIP13 drives the tumorigenesis of bladder cancer in association with the EGFR signaling pathway","volume":"15","author":"Gao","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e6036","DOI":"10.7717\/peerj.6036","article-title":"Identification of key candidate genes and biological pathways in bladder cancer","volume":"6","author":"Gao","year":"2018","journal-title":"PeerJ"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1200\/JCO.2001.19.3.666","article-title":"Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients","volume":"19","author":"Stein","year":"2001","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Zhang, C., Berndt-Paetz, M., and Neuhaus, J. (2020). Identification of Key Biomarkers in Bladder Cancer: Evidence from a Bioinformatics Analysis. Diagnostics, 10.","DOI":"10.3390\/diagnostics10020066"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"ref_13","first-page":"A68","article-title":"The Cancer Genome Atlas (TCGA): An immeasurable source of knowledge","volume":"19","author":"Tomczak","year":"2015","journal-title":"Contemp. Oncol. (Pozn. Pol.)"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1002\/pmic.201400515","article-title":"FunRich: An open access standalone functional enrichment and interaction network analysis tool","volume":"15","author":"Pathan","year":"2015","journal-title":"Proteomics"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s41065-018-0061-9","article-title":"Identification of potential crucial genes and construction of microRNA-mRNA negative regulatory networks in osteosarcoma","volume":"155","author":"Pan","year":"2018","journal-title":"Hereditas"},{"key":"ref_16","first-page":"282","article-title":"Computing topological parameters of biological networks","volume":"24","author":"Assenov","year":"2008","journal-title":"Bioinformatics (Oxf. Engl.)"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1109\/TCBB.2014.2361348","article-title":"ClusterViz: A Cytoscape APP for Cluster Analysis of Biological Network","volume":"12","author":"Wang","year":"2015","journal-title":"IEEE\/ACM Trans. Comput. Biol. Bioinform."},{"key":"ref_18","first-page":"431","article-title":"Cytoscape 2.8: New features for data integration and network visualization","volume":"27","author":"Smoot","year":"2011","journal-title":"Bioinformatics (Oxf. Engl.)"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Zaravinos, A., Lambrou, G.I., Boulalas, I., Delakas, D., and Spandidos, D.A. (2011). Identification of common differentially expressed genes in urinary bladder cancer. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0018135"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Zaravinos, A., Lambrou, G.I., Volanis, D., Delakas, D., and Spandidos, D.A. (2011). Spotlight on differentially expressed genes in urinary bladder cancer. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0018255"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1080\/15384101.2017.1417706","article-title":"A method of gene expression data transfer from cell lines to cancer patients for machine-learning prediction of drug efficiency","volume":"17","author":"Borisov","year":"2018","journal-title":"Cell Cycle (Georget. Tex.)"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.18632\/oncotarget.2833","article-title":"Knockdown of a novel lincRNA AATBC suppresses proliferation and induces apoptosis in bladder cancer","volume":"6","author":"Zhao","year":"2015","journal-title":"Oncotarget"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/s41419-018-1109-5","article-title":"CIRBP is a novel oncogene in human bladder cancer inducing expression of HIF-1alpha","volume":"9","author":"Lu","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3781904","DOI":"10.1155\/2017\/3781904","article-title":"Knockdown of SIRT1 Suppresses Bladder Cancer Cell Proliferation and Migration and Induces Cell Cycle Arrest and Antioxidant Response through FOXO3a-Mediated Pathways","volume":"2017","author":"Hu","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1172\/JCI96218","article-title":"Long noncoding RNA BLACAT2 promotes bladder cancer-associated lymphangiogenesis and lymphatic metastasis","volume":"128","author":"He","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/0470857897.ch8","article-title":"The KEGG database","volume":"247","author":"Kanehisa","year":"2002","journal-title":"Novartis Found. Symp."},{"key":"ref_28","first-page":"S96","article-title":"Histological variants of urothelial carcinoma: Diagnostic, therapeutic and prognostic implications","volume":"22","author":"Amin","year":"2009","journal-title":"Mod. Pathol. Off. J. U. S. Can. Acad. Pathol. Inc."},{"key":"ref_29","first-page":"297","article-title":"Identification of key genes associated with bladder cancer using gene expression profiles","volume":"15","author":"Han","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Hu, J., Zhou, L., Song, Z., Xiong, M., Zhang, Y., Yang, Y., Chen, K., and Chen, Z. (2019). The identification of new biomarkers for bladder cancer: A study based on TCGA and GEO datasets. J. Cell. Physiol.","DOI":"10.1002\/jcp.28208"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5301\/tj.5000196","article-title":"Identification of new hub genes associated with bladder carcinoma via bioinformatics analysis","volume":"101","author":"Jia","year":"2015","journal-title":"Tumori"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jso.25446","article-title":"Identification of a nine-gene panel as a prognostic indicator for recurrence with muscle-invasive bladder cancer","volume":"119","author":"Han","year":"2019","journal-title":"J. Surg. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Jiang, W.D., and Yuan, P.C. (2019). Molecular network-based identification of competing endogenous RNAs in bladder cancer. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0220118"},{"key":"ref_34","first-page":"3024","article-title":"Identification of Core Genes and Key Pathways via Integrated Analysis of Gene Expression and DNA Methylation Profiles in Bladder Cancer","volume":"24","author":"Zhang","year":"2018","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1158\/1078-0432.CCR-04-2409","article-title":"Bladder cancer outcome and subtype classification by gene expression","volume":"11","author":"Blaveri","year":"2005","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1158\/0008-5472.CAN-03-3620","article-title":"Gene expression in the urinary bladder: A common carcinoma in situ gene expression signature exists disregarding histopathological classification","volume":"64","author":"Dyrskjot","year":"2004","journal-title":"Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1200\/JCO.2009.25.0977","article-title":"Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors","volume":"28","author":"Lee","year":"2010","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1158\/1078-0432.CCR-03-0134","article-title":"Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: Use of cDNA array analysis of gene expression profiles","volume":"10","author":"Modlich","year":"2004","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1200\/JCO.2005.03.2375","article-title":"Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays","volume":"24","author":"Socci","year":"2006","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.3892\/or.2017.5946","article-title":"Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis","volume":"38","author":"Li","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Chin, C.H., Chen, S.H., Wu, H.H., Ho, C.W., Ko, M.T., and Lin, C.Y. (2014). cytoHubba: Identifying hub objects and sub-networks from complex interactome. BMC Syst. Biol., 8.","DOI":"10.1186\/1752-0509-8-S4-S11"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1186\/gb-2007-8-9-r183","article-title":"The DAVID Gene Functional Classification Tool: A novel biological module-centric algorithm to functionally analyze large gene lists","volume":"8","author":"Huang","year":"2007","journal-title":"Genome Biol."}],"container-title":["Data"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2306-5729\/5\/2\/38\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:30:51Z","timestamp":1760362251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2306-5729\/5\/2\/38"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,16]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["data5020038"],"URL":"https:\/\/doi.org\/10.3390\/data5020038","relation":{},"ISSN":["2306-5729"],"issn-type":[{"value":"2306-5729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,16]]}}}